2020 Digital Health Drug Development Health Data 
Lloyd Price
JUNE 17, 2023
The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.
Digital Health Global
NOVEMBER 2, 2023
Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. There are three main advantages to the use of AI in drug development: width of research, speed of execution, low costs. DiMasi, H.G.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Lloyd Price
DECEMBER 11, 2023
The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”
Waracle
JANUARY 5, 2022
In 2020, we saw the world’s first AI-developed medicine by drug discovery company Exscientia. Since their first compound DSP-1181, which was designed to help with OCD treatment, went into clinical trials, they have developed multiple other compounds using AI.
Healthcare IT News - Telehealth
MAY 6, 2020
Editor’s Note: This feature story initially was published on May 6, 2020. In 2019, Fitbit unveiled a more data-driven personal health subscription service for consumers that, among other features, generates personal reports that a user can download and share with their physician, nutritionist or personal trainer.
Expert insights. Personalized for you.
78 
Let's personalize your content